Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acorda Therapeutics
Pharma
Acorda files for bankruptcy, inks $185M asset deal to Merz
Merz, in a "stalking horse bid," agreed to pick up Acorda's Parkinson's disease med Inbrija and multiple sclerosis drug Amprya.
Zoey Becker
Apr 9, 2024 8:29am
Fighting talk: Acorda gets combative in new Parkinson's campaign
Aug 3, 2023 8:00am
Acorda slashes jobs again as generics hamper sales of MS drug
Sep 9, 2021 12:31pm
Sunovion launches Parkinson's med Kynmobi into a crowded market
Oct 14, 2020 7:35am
Acorda inks Ampyra generic pacts as Ampyra appeal pends
Aug 6, 2018 10:37am
AbbVie, Allergan could join Biogen, UCB in Acorda hunt: analyst
Feb 16, 2018 10:56am